Orchestra BioMed to present AVIM therapy data at medical conferences Mar 3, 2026 08:00AM
TD Cowen Starts Orchestra BioMed Inc. (OBIO) at Buy Dec 10, 2025 08:24AM
Orchestra BioMed (OBIO) Misses Q3 EPS by 40c Nov 11, 2025 06:57AM
Piper Sandler on Orchestra BioMed Inc. (OBIO): 'Recent Updates a Clear Positive for the Story' Sep 11, 2025 07:59AM
Orchestra BioMed presents data showing sustained blood pressure drops Sep 4, 2025 05:00PM


Sep 4, 2025 06:41AM Orchestra BioMed Inc. (OBIO) PT Lowered to $10 at H.C. Wainwright
Aug 26, 2025 07:35AM Orchestra BioMed publishes clinical data on blood pressure therapy
Aug 20, 2025 05:32AM BTIG Downgrades Orchestra BioMed Inc. (OBIO) to Neutral
Aug 14, 2025 08:04AM Orchestra BioMed reports therapy improved heart function in hypertension study
Aug 12, 2025 09:50AM Orchestra BioMed (OBIO) Misses Q2 EPS by 50c
Aug 8, 2025 07:01AM Orchestra BioMed expands patient eligibility for hypertension study
Aug 5, 2025 07:02AM Orchestra BioMed raises $111 million through equity offerings and partnerships
Jul 31, 2025 04:01PM Ligand and Medtronic invest $70 million in Orchestra BioMed
May 13, 2025 04:51PM Orchestra BioMed (OBIO) Misses Q1 EPS by 49c
May 5, 2025 07:18AM Orchestra BioMed Inc. (OBIO) PT Lowered to $12 at Barclays
Apr 29, 2025 09:08AM Orchestra BioMed (OBIO) Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing Virtue SAB
Apr 24, 2025 07:08AM H.C. Wainwright Reiterates Buy Rating on Orchestra BioMed Inc. (OBIO)
Apr 22, 2025 07:03AM Orchestra BioMed (OBIO) Receives FDA Breakthrough Device Designation for AVIM Therapy
Apr 4, 2025 06:40AM Orchestra BioMed Inc. (OBIO) PT Lowered to $12 at H.C. Wainwright
Apr 1, 2025 12:11PM BTIG Reiterates Buy Rating on Orchestra BioMed Inc. (OBIO)
Mar 20, 2025 05:33AM BTIG Starts Orchestra BioMed Inc. (OBIO) at Buy
Mar 10, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on Orchestra BioMed Inc. (OBIO)
Feb 12, 2025 10:43AM Orchestra BioMed (OBIO) Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at
Jan 2, 2025 04:51AM Barclays Starts Orchestra BioMed Inc. (OBIO) at Overweight
Aug 22, 2024 06:32AM H.C. Wainwright Starts Orchestra BioMed Inc. (OBIO) at Buy